What is Diagnostic Robotics?
Diagnostic Robotics is at the forefront of revolutionizing healthcare efficiency with its AI-powered solutions. The company's flagship virtual assistant, Maxine, automates administrative tasks, enhances communication between providers, payers, and patients, and addresses critical healthcare needs such as medication adherence and appointment scheduling. By offering tools designed to maximize value for Accountable Care Organizations (ACOs) and improve overall health outcomes, Diagnostic Robotics empowers healthcare providers and health plans to streamline workflows, reduce operational costs, and foster more meaningful patient-provider interactions. The company's focus on innovative technology positions it as a key player in the digital health transformation.
How much funding has Diagnostic Robotics raised?
Diagnostic Robotics has raised a total of $69M across 2 funding rounds:
Series A
$24M
Series B
$45M
Series A (2019): $24M with participation from Accelmed, Mivtach Shamir Holdings, Alpha Capital Partners, and Maverick Ventures Israel
Series B (2022): $45M led by Midgal Insurance, Clal Insurance, StageOne Ventures, Mayo Clinic, and Bank Hapoalim
Key Investors in Diagnostic Robotics
StageOne Ventures
StageOne Ventures specializes in leading investments in early-stage, Israel-related deep tech startups that address complex enterprise challenges. With over $500 million under management and a strong global network, they provide essential support to founders from inception to exit.
Mayo Clinic
Mayo Clinic is a nonprofit global healthcare organization specializing in integrated clinical practice, education, and medical research. Founded in 1864, the institution operates numerous hospitals and clinics across multiple international locations, offering comprehensive medical services.
Accelmed
Founded in 2009, Accelmed is a United States/Israel-based firm investing in HealthTech companies (medical device, diagnostics, and digital health) across all stages. They are based out of New York City and Herzliya, Israel.
What's next for Diagnostic Robotics?
The recent major strategic investment in Diagnostic Robotics signals a strong confidence in the company's future growth and its capacity to scale its AI-driven healthcare solutions. This capital infusion is expected to fuel further development of its virtual assistant technology, expand its market reach, and enhance its offerings for healthcare providers and payers. As Diagnostic Robotics continues its expansion, it is poised to further solidify its position as a leader in AI for healthcare, driving efficiency and improving patient care outcomes across the industry.
See full Diagnostic Robotics company page
